• Japanese
  • Korean
  • Chinese
Cover Image

Future Horizons and Growth Strategies in the US Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts

Comprehensive 880-page market segmentation analysis of the US NAT market.
  • Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Table of Contents

    Introduction

    Worldwide Market And Technology Overview

    A. DNA Sequencing

    • 1. Introduction
    • 2. Sequencing Methods
    • 3. Autoradiography
    • 4. The Human Genome Project
    • 5. Sequencing Automation
    • 6. Image Scanners
    • 7. Fluorescent Detection
    • 8. Gene Profiling
    • 9. Gene Expression
    • 10. Polymorphism Screening
    • 11. Protein Interaction Networks

    B. DNA And RNA Probe Technology

    • 1. Basic Principles
    • 2. Probe Preparation
    • 3. The DNA Probe Test
      • a. Sample Preparation
      • b. Hybridization
      • c. Separation
      • d. Detection/Measurement
    • 4. Test Formats
      • a. Filter Hybridization
      • b. Southern Blot
      • c. Northern Blot
      • d. In Situ Hybridization
      • e. Others
    • 5. Labeling Techniques
    • 6. Amplification Methods
      • Polymerase Chain Reaction
        • Temperature Cyclers
        • PCR Variations
          • Immuno-PCR
          • QC-PCR
          • DAP-PCR
      • Strand Displacement Activation
      • TMA
      • Ligase Chain Reaction
      • Branched DNA
        • Hybridization Protection Assay
      • Nucleic-Acid Sequence-Based Amplification
      • Self-Sustained Sequence Replicase
      • Others
        • Ampliprobe
        • CAR
        • CAS
        • CPT
        • Dendritic Polymer Technology
        • ISO-CR
        • LAT
        • Probe Networks
        • RAMP
        • Repair Chain Reaction
        • Rolling Circles
        • Sequence Independent Gene Amplification
        • Sequence Initiation Reaction
        • SISPA
        • Solid Phase Amplification

    C. Detection Technologies

    1. Radioactive Methods

    • a. Overview
    • b. Major Isotopes
      • P-32
      • S-35
      • H-3
      • I-125

    2. Non-Isotopic Methods

    • a. Enzymatic Labels
    • b. Chemical Labeling
      • Indirect Chemical Labeling
      • Direct Chemical Labeling
    • c. Fluorescence
    • d. Chemiluminescence
    • e. Electrical Conductivity

    D. Instrumentation Review

    • 1. Abbott LCx
    • 2. Beckman Coulter/Biomek FK
    • 3. Becton Dickinson SDA
    • 4. Bio-Rad GeneScope
    • 5. Gen-Probe Tigris
    • 6. Roche Cobas Amplicor
    • 7. Tecan LS Series

    E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip

    • Liquid Transportation and Mixing
    • Separation
    • Reaction
    • Detection

    F. Pharmacogenomics

    G. Major Applications

    1. Microbiology/Infectious Diseases

    • a. Overview
    • b. Major Infectious Diseases
    • * AIDS
      • Structure and Composition
      • Classification
      • AIDS Origins
      • Animal Lentivirus Systems
      • Virus Receptors
      • HIV Infections in Humans
        • Pathogenesis and Pathology
      • CD4T Lymphocytes and Memory Cells
      • Monocytes and Macrophages
      • Lymphoid Organs
      • Neural Cells
      • Viral Coinfections
        • Clinical Findings
      • Plasma Viral Load
      • Pediatric AIDS
        • Neurologic Disease
        • Opportunistic Infections
        • Cancer
      • Immunity
        • Virus Isolation
        • Serology
        • Viral Nucleic Acid/Antigen Detection
      • Epidemiology
        • Worldwide Spread of AIDS
        • United States
        • Routes of Transmission
      • DNA Probes
        • Overview
        • Quantitative PCR
        • In Situ PCR
        • Needed Improvements
      • Viral Load/Drug Resistance Testing
      • Genotype and Phenotype Testing
      • Blood Banking Considerations
    • * Adenovirus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
      • Adeno-Associated Viruses (AAV)
    • * Anthrax/Bacillus Anthracis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Babesiosis
      • Background
    • * BEA and Other Bartonella Diseases
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Chagas Disease
      • Background
    • * Campylobacter
      • Background
      • Diagnostic Tests
        • Culture Identification
      • Vaccines and Drugs
    • * Chlamydia
      • Background
        • Chlamydia psittaci
        • Chlmaydia pneumoniae
        • Chlamydia trachomatis
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Creutzfeldt-Jakob's Disease
      • Background
      • Blood Transmission
      • Diagnostic Tests
      • Major Commercial and Academic Players
        • Bayer
        • Disease Sciences/BiTec Global
        • Imperial College School of Medicine
        • Ortho-Clinical Diagnostics
        • Pall
        • ProMetic Life Sciences
        • Proteome Sciences/Idexx
        • Q-One Biotech
        • Serono
        • U.S. Agricultural Research Service
      • Drugs
      • Vaccines
    • * Cytomegalovirus
      • Background
        • Chorioretinitis
        • Gastrointestinal
        • Central Nervous System Disease
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Ebola Virus
      • Background
        • Epidemiology
        • Clinical Syndromes
      • Diagnostic Tests
      • Vaccines and Drugs
    • * EchoVirus
      • Background
        • Acute Aseptic Meningitisis
        • Encephalitis
        • Exanthems
        • Respiratory Disease
        • Myopericarditis
        • Neonatal Infections
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Encephalitis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Enteroviruses
      • Background
      • Diagnostic Tests
        • Viral Isolation and Identification
        • Antibody Tests
      • Vaccines and Drugs
    • * Epstein-Barr Virus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Gonorrhea
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Hepatitis
      • Hepatitis A
      • Hepatitis B
        • Structure and Composition
        • Replication
      • Hepatitis C
      • Hepatitis D (Delta)
      • Hepatitis E
      • Hepatitis G
      • Hepatitis Infections Pathology
      • Clinical Findings
      • Laboratory Tests
        • Hepatitis A
        • Hepatitis B
        • Hepatitis C
        • Hepatitis D
        • Hepatitis E
      • Virus-Host Immune Reactions
      • Epidemiology
        • Hepatitis A
        • Hepatitis B
        • Hepatitis C
        • Hepatitis D (Delta)
      • Vaccines and Drugs
    • * Herpes Simplex Virus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Legionella
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Lyme Disease
      • Background
        • Clinical Description
        • Clinical Case Definition
        • Laboratory Criteria for Diagnosis
        • Case Classification
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Malaria
    • * Mycoplasma
      • Background
        • Ureaplasma Urealyticum & Mycoplasma
    • Hominis
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Papillomaviruses/HPV
      • Background
        • HPV in Cancer
        • Cervical Neoplasm
      • Diagnostic Tests
      • Vaccines and Drugs
        • Prevention
    • * Parvovirus B19
      • Background
        • Microbiology
        • Epidemiology
        • Clinical Syndromes
        • Erythema Infectiosum (Slapped Cheek)
        • Adult Polyarthropathy
        • Transient Aplastic Crisis
        • Transient Pancytopenia
        • Red Cell Aplasia in Immunocompromised
        • Perinatal Infections
      • Diagnostic Test
      • Vaccines and Drugs
    • * Pneumonia
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Polyomaviruses
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Salmonellosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Shigellosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Streptococci
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
        • Group A Streptococci
        • Group B Streptococci
    • * Toxoplasmosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Tuberculosis
      • Background
      • Diagnostic Tests
        • Microscopic Characteristics
        • Cultural Characteristics
        • Skin Tests
        • MDRTB
      • Vaccines and Drugs
    • * West Nile Virus
      • Background
        • Clinical Syndromes
      • Diagnostic Tests
      • Vaccines and Drugs
    • * Yersinia
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • c. Antibiotic Susceptibility

    2. Cancer Testing

    • a. Overview
    • b. Major Cancer Types
      • Prostate
      • Lung
      • Colon and Rectum
      • Breast
      • Skin
      • Uterine
      • Leukemia
      • Oral
    • c. Oncogenes
      • Abl/abl-bcr
      • AIB1
      • BCL-2
      • BRCA1
      • CD44
      • C-fos
      • C-myb
      • C-myc
      • CYP17
      • Erb-B
      • HPC1
      • N-myc
      • P40
      • P51
      • P53
      • PIK3CA
      • PTI-1
      • Ras
      • Reg
      • Sis
      • Src

    3. Genetic Diseases

    • a. Overview
    • b. Nucleic Acid Amplification
    • c. Chromosome Imaging
    • d. Genomics Technologies
    • e. Proteomics Technologies
    • f. Current Pharmacogenomic Tests
    • g. Future Pharmacogenomic Testing
    • h. Major Diseases
      • Achondroplasia
      • Autosomal Dominant Polycystic Kidney Disease
      • Cancer
      • Cosmetogenomics
      • Cystic Fibrosis
      • Down's Syndrome
      • Duchenne and Becker Muscular Dystrophy
      • Factor V (Leiden)
      • Factor IX Deficiency
      • Fragile X Syndrome
      • Heart Disease
      • Hemochomatosis
      • Hemophilia
      • Huntington's Disease
      • Maternal-Fetal Incompatibility
      • Multiple Endocrine Neoplasia
      • Phenylketonuria (PKU)
      • Polycystic Kidney Disease (PKD)
      • Prenatal Screening
      • Retinitis Pigmentosa
      • Retinoblastoma
      • Sickle Cell Anemia
      • Spinal Muscular Atrophy
      • Vitamin B12 Metabolism
    • i. Social Issues and Concerns

    4. Forensic Testing

    • a. Overview
    • b. Multilocus and Single Locus Probes
      • Multilocus Probes
      • Single Locus Probes
      • PCR and RFLP
    • c. The FBI
    • d. DNA Profile Data Banks
      • U.S.A.
      • U.K.
    • e. Judicial Implementation
    • f. Major Crime Categories
    • g. Factors Contributing to the DNA Probe Market Expansion
      • Technology Availability
      • Use of Hair as Evidence
    • h. Wildlife Forensics

    5. Paternity Testing/HLA Typing

    6. Other Applications

    • a. Disease Susceptibility Testing
    • b. Cardiovascular Diseases
    • c. Diabetes
    • d. Alzheimer's Disease
    • e. Periodontal Disease
    • f. Plasma Purification
    • g. Organ Transplantation
    • h. Water Contamination
    • i. Other

    H. Competing/complementing Technologies

    • 1. Monoclonal Antibodies/Immunoassays
    • 2. RNA Probes
    • 3. Two-Dimensional Electrophoresis
    • 4. Flow Cytometry

    I. Worldwide Market Overview

    • 1. Business Environment
    • 2. Market Structure
    • 3. Market Size and Growth

    USA

    • A. Executive Summary
    • B. Business Environment
    • C. Market Structure
    • D. Market Size, Growth And Major Suppliers'Sales And Market Shares

    Major Product Development Opportunities

    • A. Instrumentation
    • B. Reagent Kits and Test Systems/panels
    • C. Computers, Software and Automation
    • D. Auxiliary Products

    Design Criteria For Decentralized Testing Products

    Alternative Market Penetration Strategies

    • A. Internal Development
    • B. Collaborative Arrangements
    • C. University Contracts
    • D. Distribution Strategies For Decentralized Testing Markets
      • 1. Marketing Approaches
      • 2. Product Complexity
      • 3. Customer Preference
      • 4. Established Suppliers
      • 5. Emerging Suppliers
      • 6. Major Types Of Distributors
      • 7. Market Segmentation

    Potential Market Entry Barriers And Risks

    • A. Market Maturity
    • B. Cost Containment
    • C. Competition
    • D. Technological Edge And Limitations
    • E. Patent Protection
    • F. Regulatory Constraints
    • G. Decentralized Testing Market Challenges

    Competitive Profiles

    • Abbott
    • Affymetrix
    • Agilent
    • Applied Gene Technologies
    • Arca
    • Beckman Coulter/Danaher
    • Becton Dickinson
    • Biokit
    • BioMerieux
    • Bio-Rad
    • Biotest
    • Caliper
    • Cepheid
    • Decode
    • Diadexus
    • Eiken
    • Enzo
    • Exact Sciences
    • Fujirebio
    • Gen-Probe
    • Hologic
    • Illumina
    • Innogenetics/Solvay
    • Kreatech
    • Li-Cor Biosciences
    • Life Technologies
    • Monogram Biosciences
    • Myriad Genetics
    • Nanogen/Elitech
    • Novartis
    • Orchid CellMark
    • Ortho-Clinical Diagnostics
    • Proteome Sciences
    • Qiagen
    • Roche
    • Scienion
    • Sequenom
    • Shimadzu
    • Siemens
    • Sierra Molecular
    • Takara Bio
    • Tecan Group

    Appendixes

    • Appendix I: Major Universities and Research Centers Developing NAT Technology
    • Appendix II: Glossary of Terms
    • Appendix III: Currency Exchange Rates

    List of Tables

    • Major Companies Developing or Marketing AIDS NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Adenovirus NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Campylobacter NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Chlamydia NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Gonorrhea NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Hepatitis NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Herpes NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Legionella NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Lyme Disease NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Mycoplasma NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Papilloma Virus NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Pneumonia NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Salmonella NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Shigella NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Streptococci NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Toxoplasmosis NAT And Other Direct Identification Tests
    • Major Companies Developing or Marketing Tuberculosis NAT And Other Direct Identification Tests
    • Oncogenes Potential Application in Cancer Diagnosis Major Companies Developing or Marketing Cancer NAT Tests
    • Major Companies Developing or Marketing NAT Assays For Genetic Diseases
    • Summary Table U.S.A., NAT Test Volume And Sales Forecast by Major Application
    • U.S.A., Laboratories Performing DNA Sequencing by Market Segment
    • U.S.A., NAT Market, Potential Laboratory Universe by Market Segment
    • U.S.A., NAT Test Volume Forecast By Major Application
    • U.S.A., Major Infectious Disease NAT Test Volume Forecast
    • U.S.A., Infectious Disease Screening NAT Volume by Test Forecast
    • U.S.A., NAT Market Forecast By Major Application
    • U.S.A., Infectious Disease Screening Nat Reagent Market Forecast by Test
    • U.S.A., NAT Market by Major Supplier
    • U.S.A., HIV/Hepatitis C NAT Market Reagent Sales By Major Supplier
    • U.S.A., West Nile Virus NAT Market Reagent Sales By Major Supplier
    Show More
    RELATED REPORTS
    * Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids
    • Published:
    • Sep 08, 2014
    • USD 3016
    • 170 Pages

    * Future Horizons and Growth Strategies in the German Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts
    • Published:
    • Aug 28, 2014
    • USD 850
    • 850 Pages

    * Future Horizons and Growth Strategies in the Global Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts
    • Published:
    • Aug 28, 2014
    • USD 20900
    • 1050 Pages

    * Future Horizons and Growth Strategies in the Japanese Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts
    • Published:
    • Aug 28, 2014
    • USD 850
    • 850 Pages

    * Future Horizons and Growth Strategies in the UK Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts
    • Published:
    • Aug 28, 2014
    • USD 855
    • 855 Pages

    * Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report
    • Published:
    • Jul 28, 2014
    • USD 4500
    • 219 Pages

    * Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018
    • Published:
    • May 16, 2014
    • USD 4650
    • 215 Pages

    * Nucleic Acid Isolation and Purification Market by Technology (Column Based, Reagent Based, Magnetic Bead based), Consumables & Instruments, by Application (Plasmid DNA Isolation, miRNA Isolation, Total RNA Isolation), End Users: Global Forecasts to 2018
    • Published:
    • Apr 25, 2014
    • USD 4650
    • 255 Pages

    * 2014 Nucleic Acid Amplification Dashboard Series 4 - NA & EU
    • Published:
    • Mar 18, 2014
    • USD 3975

    * Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018
    • Published:
    • Feb 14, 2014
    • USD 2500
    • 74 Pages

    Browse more In Vitro Diagnostics Market Research Reports

    Pricing
    Get Notified
    Email me when related reports are published